Related Experiment Video

Updated: Aug 16, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

[Prevention of cardiovascular diseases by hormone replacement in postmenopause]

E Windler1

  • 1Medizinische Kernklinik and Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg.

Zentralblatt Fur Gynakologie
|January 1, 1996
PubMed

Insights

Hormone replacement therapy can significantly reduce cardiovascular disease risk in postmenopausal women by improving cholesterol levels and blood pressure. This intervention offers a vital strategy for preventing cardiovascular deaths in women.

Area of Science:

  • Cardiology
  • Endocrinology
  • Women's Health

Context:

  • Cardiovascular disease (CVD) is a leading cause of mortality in women.
  • Postmenopause is associated with increased CVD risk factors including hypertension, diabetes, elevated LDL-cholesterol, and lipoprotein (a).
  • Coronary artery disease incidence rises significantly after menopause.

Purpose:

  • To evaluate the role of hormone replacement therapy (HRT) in preventing cardiovascular disease in women.
  • To assess the impact of HRT on key cardiovascular risk factors.

Summary:

  • Estrogen in HRT effectively lowers LDL-cholesterol by up to 20% and increases HDL-cholesterol by up to 30%.
  • These beneficial lipid-modifying effects are sustained even with the co-administration of a progestin.
  • Large-scale studies suggest HRT can reduce cardiovascular mortality by approximately 50%.

Impact:

  • HRT represents a crucial preventive strategy for cardiovascular disease in postmenopausal women.
  • Despite potential adverse events, the substantial reduction in overall mortality underscores HRT's significant public health benefit.
  • Normalizing risk factors through HRT is vital for women's cardiovascular health.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Related Concept Videos

Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...